We further show that these effects are mediated through the Smad pathway and that Smad3/4 gene silencing by means of CRISPR/Cas9 knockout (KO) could prevent the TGFβ anti-stemness effects in melanoma. The gene discussed is TGFB1; the disease is melanoma.